Skip to main content
NCBI home page
Journal of Clinical Microbiology logoLink to Journal of Clinical Microbiology
. 1996 Aug;34(8):1934–1938. doi: 10.1128/jcm.34.8.1934-1938.1996

Development of novel assays for botulinum type A and B neurotoxins based on their endopeptidase activities.

B Hallis 1, B A James 1, C C Shone 1
PMCID: PMC229157  PMID: 8818885

Abstract

A novel assay method based on the endopeptidase activities of the botulinum neurotoxins has been developed and applied to the detection of botulinum type A and B toxins. An assay system developed for the detection of botulinum type B neurotoxin (BoNT/B) is based on the cleavage of a synthetic peptide substrate representing amino acid residues 60 to 94 of the intracellular target protein for the toxin, VAMP (vesicle-associated membrane protein, or synaptobrevin). In this assay system, immobilized VAMP (60-94) peptide substrate is cleaved by BoNT/B at the Gln-76-Phe-77 bond, leaving the C-terminal cleavage fragment on the solid phase. This fragment is then detected by the addition of an antibody-enzyme reagent which specifically recognizes the newly exposed N terminus of the cleavage product. The developed assay was specific to BoNT/B, showing no cross-reactivity with other clostridial neurotoxins, and had a sensitivity for BoNT/B of 0.6 to 4.5 ng/ml, which could be increased to 0.1 to 0.2 ng/ml by using an assay amplification system based on catalyzed reporter deposition. Trypsin treatment of BoNT/B samples, which converts the single-chain toxin to the active di-chain form, was found to increase the sensitivity of the endopeptidase assay from 5- to 10-fold. An endopeptidase assay for BoNT/A, based on the cleavage of a peptide substrate derived from the protein SNAP-25 (synaptosome-associated protein), was also developed and characterized.

Full Text

The Full Text of this article is available as a PDF (250.2 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Blasi J., Chapman E. R., Link E., Binz T., Yamasaki S., De Camilli P., Südhof T. C., Niemann H., Jahn R. Botulinum neurotoxin A selectively cleaves the synaptic protein SNAP-25. Nature. 1993 Sep 9;365(6442):160–163. doi: 10.1038/365160a0. [DOI] [PubMed] [Google Scholar]
  2. Bobrow M. N., Harris T. D., Shaughnessy K. J., Litt G. J. Catalyzed reporter deposition, a novel method of signal amplification. Application to immunoassays. J Immunol Methods. 1989 Dec 20;125(1-2):279–285. doi: 10.1016/0022-1759(89)90104-x. [DOI] [PubMed] [Google Scholar]
  3. Doellgast G. J., Beard G. A., Bottoms J. D., Cheng T., Roh B. H., Roman M. G., Hall P. A., Triscott M. X. Enzyme-linked immunosorbent assay and enzyme-linked coagulation assay for detection of Clostridium botulinum neurotoxins A, B, and E and solution-phase complexes with dual-label antibodies. J Clin Microbiol. 1994 Jan;32(1):105–111. doi: 10.1128/jcm.32.1.105-111.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Doellgast G. J., Triscott M. X., Beard G. A., Bottoms J. D., Cheng T., Roh B. H., Roman M. G., Hall P. A., Brown J. E. Sensitive enzyme-linked immunosorbent assay for detection of Clostridium botulinum neurotoxins A, B, and E using signal amplification via enzyme-linked coagulation assay. J Clin Microbiol. 1993 Sep;31(9):2402–2409. doi: 10.1128/jcm.31.9.2402-2409.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Evans D. M., Williams R. S., Shone C. C., Hambleton P., Melling J., Dolly J. O. Botulinum neurotoxin type B. Its purification, radioiodination and interaction with rat-brain synaptosomal membranes. Eur J Biochem. 1986 Jan 15;154(2):409–416. doi: 10.1111/j.1432-1033.1986.tb09413.x. [DOI] [PubMed] [Google Scholar]
  6. Foran P., Lawrence G. W., Shone C. C., Foster K. A., Dolly J. O. Botulinum neurotoxin C1 cleaves both syntaxin and SNAP-25 in intact and permeabilized chromaffin cells: correlation with its blockade of catecholamine release. Biochemistry. 1996 Feb 27;35(8):2630–2636. doi: 10.1021/bi9519009. [DOI] [PubMed] [Google Scholar]
  7. Foran P., Shone C. C., Dolly J. O. Differences in the protease activities of tetanus and botulinum B toxins revealed by the cleavage of vesicle-associated membrane protein and various sized fragments. Biochemistry. 1994 Dec 27;33(51):15365–15374. doi: 10.1021/bi00255a017. [DOI] [PubMed] [Google Scholar]
  8. Gibson A. M., Modi N. K., Roberts T. A., Shone C. C., Hambleton P., Melling J. Evaluation of a monoclonal antibody-based immunoassay for detecting type A Clostridium botulinum toxin produced in pure culture and an inoculated model cured meat system. J Appl Bacteriol. 1987 Sep;63(3):217–226. doi: 10.1111/j.1365-2672.1987.tb04939.x. [DOI] [PubMed] [Google Scholar]
  9. Minton N. P. Molecular genetics of clostridial neurotoxins. Curr Top Microbiol Immunol. 1995;195:161–194. doi: 10.1007/978-3-642-85173-5_8. [DOI] [PubMed] [Google Scholar]
  10. Schiavo G., Benfenati F., Poulain B., Rossetto O., Polverino de Laureto P., DasGupta B. R., Montecucco C. Tetanus and botulinum-B neurotoxins block neurotransmitter release by proteolytic cleavage of synaptobrevin. Nature. 1992 Oct 29;359(6398):832–835. doi: 10.1038/359832a0. [DOI] [PubMed] [Google Scholar]
  11. Schiavo G., Poulain B., Benfenati F., DasGupta B. R., Montecucco C. Novel targets and catalytic activities of bacterial protein toxins. Trends Microbiol. 1993 Aug;1(5):170–174. doi: 10.1016/0966-842x(93)90086-7. [DOI] [PubMed] [Google Scholar]
  12. Schiavo G., Rossetto O., Catsicas S., Polverino de Laureto P., DasGupta B. R., Benfenati F., Montecucco C. Identification of the nerve terminal targets of botulinum neurotoxin serotypes A, D, and E. J Biol Chem. 1993 Nov 15;268(32):23784–23787. [PubMed] [Google Scholar]
  13. Schiavo G., Santucci A., Dasgupta B. R., Mehta P. P., Jontes J., Benfenati F., Wilson M. C., Montecucco C. Botulinum neurotoxins serotypes A and E cleave SNAP-25 at distinct COOH-terminal peptide bonds. FEBS Lett. 1993 Nov 29;335(1):99–103. doi: 10.1016/0014-5793(93)80448-4. [DOI] [PubMed] [Google Scholar]
  14. Schiavo G., Shone C. C., Bennett M. K., Scheller R. H., Montecucco C. Botulinum neurotoxin type C cleaves a single Lys-Ala bond within the carboxyl-terminal region of syntaxins. J Biol Chem. 1995 May 5;270(18):10566–10570. doi: 10.1074/jbc.270.18.10566. [DOI] [PubMed] [Google Scholar]
  15. Schiavo G., Shone C. C., Rossetto O., Alexander F. C., Montecucco C. Botulinum neurotoxin serotype F is a zinc endopeptidase specific for VAMP/synaptobrevin. J Biol Chem. 1993 Jun 5;268(16):11516–11519. [PubMed] [Google Scholar]
  16. Shone C. C., Melling J. Inhibition of calcium-dependent release of noradrenaline from PC12 cells by botulinum type-A neurotoxin. Long-term effects of the neurotoxin on intact cells. Eur J Biochem. 1992 Aug 1;207(3):1009–1016. doi: 10.1111/j.1432-1033.1992.tb17137.x. [DOI] [PubMed] [Google Scholar]
  17. Shone C. C., Quinn C. P., Wait R., Hallis B., Fooks S. G., Hambleton P. Proteolytic cleavage of synthetic fragments of vesicle-associated membrane protein, isoform-2 by botulinum type B neurotoxin. Eur J Biochem. 1993 Nov 1;217(3):965–971. doi: 10.1111/j.1432-1033.1993.tb18327.x. [DOI] [PubMed] [Google Scholar]
  18. Shone C. C., Roberts A. K. Peptide substrate specificity and properties of the zinc-endopeptidase activity of botulinum type B neurotoxin. Eur J Biochem. 1994 Oct 1;225(1):263–270. doi: 10.1111/j.1432-1033.1994.00263.x. [DOI] [PubMed] [Google Scholar]
  19. Shone C. C., Tranter H. S. Growth of clostridia and preparation of their neurotoxins. Curr Top Microbiol Immunol. 1995;195:143–160. doi: 10.1007/978-3-642-85173-5_7. [DOI] [PubMed] [Google Scholar]
  20. Shone C., Wilton-Smith P., Appleton N., Hambleton P., Modi N., Gatley S., Melling J. Monoclonal antibody-based immunoassay for type A Clostridium botulinum toxin is comparable to the mouse bioassay. Appl Environ Microbiol. 1985 Jul;50(1):63–67. doi: 10.1128/aem.50.1.63-67.1985. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Söllner T., Whiteheart S. W., Brunner M., Erdjument-Bromage H., Geromanos S., Tempst P., Rothman J. E. SNAP receptors implicated in vesicle targeting and fusion. Nature. 1993 Mar 25;362(6418):318–324. doi: 10.1038/362318a0. [DOI] [PubMed] [Google Scholar]
  22. Wadsworth J. D., Desai M., Tranter H. S., King H. J., Hambleton P., Melling J., Dolly J. O., Shone C. C. Botulinum type F neurotoxin. Large-scale purification and characterization of its binding to rat cerebrocortical synaptosomes. Biochem J. 1990 May 15;268(1):123–128. doi: 10.1042/bj2680123. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Journal of Clinical Microbiology are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES